Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial

Morgan Stanley (MS) Stock Forecast & Price Target

Morgan Stanley logo
$132.07 -0.17 (-0.13%)
(As of 12:20 PM ET)

Morgan Stanley - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
10
Buy
8

Based on 18 Wall Street analysts who have issued ratings for Morgan Stanley in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 18 analysts, 10 have given a hold rating, 7 have given a buy rating, and 1 has given a strong buy rating for MS.

Consensus Price Target

$112.94
-14.49% Downside
According to the 18 analysts' twelve-month price targets for Morgan Stanley, the average price target is $112.94. The highest price target for MS is $142.00, while the lowest price target for MS is $80.00. The average price target represents a forecasted downside of -14.49% from the current price of $132.07.

MS Analyst Ratings Over Time

TypeCurrent Forecast
11/21/23 to 11/20/24
1 Month Ago
10/22/23 to 10/21/24
3 Months Ago
8/23/23 to 8/22/24
1 Year Ago
11/21/22 to 11/21/23
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
1 Strong Buy rating(s)
Buy
7 Buy rating(s)
7 Buy rating(s)
7 Buy rating(s)
7 Buy rating(s)
Hold
10 Hold rating(s)
11 Hold rating(s)
12 Hold rating(s)
8 Hold rating(s)
Sell
0 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$112.94$107.56$101.45$94.18
Forecasted Upside-14.49% Downside-9.06% Downside0.84% Upside20.01% Upside
Consensus Rating
Moderate Buy
Hold
Hold
Moderate Buy

MS Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

MS Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Morgan Stanley Stock vs. The Competition

TypeMorgan StanleyFinance CompaniesS&P 500
Consensus Rating Score
2.50
2.49
2.50
Consensus RatingModerate BuyHoldModerate Buy
Predicted Upside-14.58% Downside12.24% Upside9.99% Upside
News Sentiment Rating
Positive News

See Recent MS News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/15/2024Wells Fargo & Company
3 of 5 stars
M. Mayo
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeUnderweight ➝ Equal Weight$107.00 ➝ $142.00+7.22%
10/17/2024The Goldman Sachs Group
2 of 5 stars
R. Ramsden
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetNeutral ➝ Neutral$106.00 ➝ $121.00+0.82%
10/17/2024Royal Bank of Canada
4 of 5 stars
 Boost TargetSector Perform ➝ Sector Perform$108.00 ➝ $122.00+1.66%
10/17/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$121.00 ➝ $135.00+13.09%
10/17/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$120.00 ➝ $135.00+12.69%
10/8/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$102.00 ➝ $112.00+3.91%
Deloitte’s #1 software company price changing (Ad)

Get in on the biggest disruption to smartphones in over a decade. Reg A investment now open.

Claim Exclusive 100% Bonus: $0.25/Share*
10/4/2024Hsbc Global Res
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Martinez
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
10/4/2024HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$118.00+12.84%
7/18/2024JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMarket Perform
7/18/2024BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$116.00 ➝ $118.00+10.42%
7/17/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$98.00 ➝ $105.00-1.83%
7/17/2024Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$105.00 ➝ $115.00+8.39%
7/17/2024Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Market Perform
4/17/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$100.00 ➝ $106.00+17.67%
4/17/2024Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetMarket Perform ➝ Market Perform$94.00 ➝ $98.00+9.18%
4/16/2024Cfra
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$97.00 ➝ $108.00+20.82%
1/17/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOverweight ➝ Neutral$94.00 ➝ $87.00+1.20%
11/28/2023Societe Generale
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$80.00+2.63%
11/20/2023BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Neutral$85.00+5.88%
10/23/2023Odeon Capital Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$79.15+8.72%
10/20/2023Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderperform ➝ Peer Perform
8/1/2023Atlantic Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$85.00 ➝ $90.00-1.70%
1/19/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$97.00 ➝ $102.00+5.61%
1/6/2023Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$92.00 ➝ $84.00-2.23%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 12:37 PM ET.


Should I Buy Morgan Stanley Stock? MS Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, November 7, 2024. Please send any questions or comments about these Morgan Stanley pros and cons to contact@marketbeat.com.

Morgan Stanley
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Morgan Stanley:

  • Morgan Stanley's Q1 2025 earnings per share estimates have been raised, indicating positive growth potential.
  • Recent insider trading activity shows confidence in the company's performance.
  • Large institutional investors have been increasing their positions in Morgan Stanley, signaling strong institutional support.
  • Analysts have given Morgan Stanley a consensus rating of "Hold" with a target price above the current stock price, suggesting potential upside.
  • Morgan Stanley's stock price has been showing an upward trend, reaching a 12-month high, which could attract more investors.

Morgan Stanley
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Morgan Stanley for these reasons:

  • Despite positive analyst ratings, some analysts have issued a sell rating on the stock, indicating potential risks.
  • The company's debt-to-equity ratio of 2.96 is relatively high, which may pose financial stability concerns.
  • There is a possibility of market volatility affecting the financial services sector, impacting Morgan Stanley's performance.
  • While the stock has reached a 12-month high, there could be a risk of a market correction affecting the stock price negatively.
  • Investors should consider the potential impact of global economic conditions on Morgan Stanley's business operations and profitability.

MS Forecast - Frequently Asked Questions

According to the research reports of 18 Wall Street equities research analysts, the average twelve-month stock price forecast for Morgan Stanley is $112.94, with a high forecast of $142.00 and a low forecast of $80.00.

18 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Morgan Stanley in the last year. There are currently 10 hold ratings, 7 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" MS shares.

According to analysts, Morgan Stanley's stock has a predicted downside of -14.49% based on their 12-month stock forecasts.

Over the previous 90 days, Morgan Stanley's stock had 3 upgrades by analysts.

Morgan Stanley has been rated by research analysts at Barclays, Hsbc Global Res, HSBC, Jefferies Financial Group, Royal Bank of Canada, The Goldman Sachs Group, UBS Group, and Wells Fargo & Company in the past 90 days.

Morgan Stanley also publishes sell-side equities research reports and recommendations about other companies, which can be viewed at its brokerage rating page.

Analysts like Morgan Stanley more than other "finance" companies. The consensus rating for Morgan Stanley is Moderate Buy while the average consensus rating for "finance" companies is Hold. Learn more on how MS compares to other companies.


This page (NYSE:MS) was last updated on 11/20/2024 by MarketBeat.com Staff
From Our Partners